Treatment of Fulminant Colitis

  • Harland Winter


Ulcerative Colitis Bloody Stool Peripherally Insert Central Catheter Toxic Megacolon Ileoanal Anastomosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hyams J, Markowitz J, Lerer T, et al. Pediatric Inflammatory Bowel Disease Collaborative Research Group. The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol & Hepatol 4(9):1118–23, 2006.CrossRefGoogle Scholar
  2. 2.
    Hyams J, Davis P, Grancher K, et al. Clinical outcome of ulcerative colitis in children, J Pediatr 129:81–88, 1996.PubMedCrossRefGoogle Scholar
  3. 3.
    Kornbluth A, Sachar DB. Ulcerative colitis: practice guidelines in adults (update): American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol 99:1371–85, 2004.PubMedCrossRefGoogle Scholar
  4. 4.
    Markowitz J, Mamula P, Baldassano R, Piccoli D. Ulcerative Colitis. Last Updated March 1, 2007.Google Scholar
  5. 5.
    Kugathasan, S, Dubinsky, MC, Keljo, D, et al. Severe Colitis in Children. J Pediatr Gastroenterol Nutr 41(4):375–385, 2005.PubMedCrossRefGoogle Scholar
  6. 6.
    Kader HA, Mascarenhas MR, Piccoli DA, et al. Experiences with 6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis. J Pediatr Gastroenterol Nutr 28:54–58, 1999.PubMedCrossRefGoogle Scholar
  7. 7.
    Bousvaros A, Kirschner BS, Werlin SL, et al. Oral tacrolimus treatment of severe colitis in children. J Pediatr 137(6):794–9, 2000.Google Scholar
  8. 8.
    Ogata H, Matsui T, Nakamura M, et al. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut 55:1255–1262, 2006.Google Scholar
  9. 9.
    Treem WR, Davis PM, Justinich CJ, Hyams JS. Cyclosporine for the treatment of fulminant ulcerative colitis in children. Immediate response, long-term results, and impact on surgery. Dis Colon Rectum 38(5):474–9, 1995.PubMedCrossRefGoogle Scholar
  10. 10.
    McCormack G, McCormick PA, Hyland JM, et al. Cyclosporine therapy in severe ulcerative colitis: is it worth the effort? Dis Colon Rectum 45:1200–5, 2002.PubMedCrossRefGoogle Scholar
  11. 11.
    Carbonnel F, Boruchowicz A, Duclos B, et al. Intravenous cyclosporine in attacks of ulcerative colitis: short-term and long-term responses. Dig Dis Sci 41:2471–6, 1996.PubMedCrossRefGoogle Scholar
  12. 12.
    Arts J, D’Haens G, Zeegers M, et al. Long-term outcome of treatment with intravenous cyclosporine in patients with severe ulcerative colitis, Inflamm Bowel Dis 10:73–8, 2004.PubMedCrossRefGoogle Scholar
  13. 13.
    Naftali T, Novis B, Pomeranz I, et al. Cyclosporine for severe ulcerative colitis. Isr Med Assoc J 2:588–91, 2000.PubMedGoogle Scholar
  14. 14.
    Van Assche G, D’Haens G, Noman M, et al. Randomized double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 125:1025–31, 2003.PubMedCrossRefGoogle Scholar
  15. 15.
    Sandborn WJ. Cyclosporin in ulcerative colitis: state of the art. Act Gastroenterol Beg 64:201–4, 2001.Google Scholar
  16. 16.
    Eidelwein AP, Cuffari C, Abadom V, Oliva-Hemker M. Infliximab efficacy in pediatric ulcerative colitis. Inflamm Bowel Dis 11(3):213–8, 2005.PubMedCrossRefGoogle Scholar
  17. 17.
    Russell GH, Katz AJ. Infliximab is effective in acute but not chronic childhood ulcerative colitis. J Pediatr Gastroenterol Nutr 39(2):166–70, 2004.PubMedCrossRefGoogle Scholar
  18. 18.
    Fanjiang G, Russell GH, Katz AJ. Short- and Long-term response to and weaning from infliximab therapy in pediatric ulcerative colitis. J Pediatr Gastro and Nutr 44:312–7, 2007.CrossRefGoogle Scholar
  19. 19.
    Su C, Salzberg BA, Lewis JD, et al. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis. Am J Gastroenterol 97:2577–84, 2002.PubMedCrossRefGoogle Scholar
  20. 20.
    Mamula P, Markowitz JE, Cohen LJ, von Allmen D, Baldassano RN. Infliximab in pediatric ulcerative colitis: two-year follow-up. J Pediatr Gastroenterol Nutr 38(3):298–301, 2004.PubMedCrossRefGoogle Scholar
  21. 21.
    Crandall WV, Mocker LM. Infusion reactions to infliximab in children and adolescents: frequency, outcome and a predictive model. Aliment Pharmacol Ther 17:75–84, 2003.PubMedCrossRefGoogle Scholar
  22. 22.
    Fabio, WA. Step-Up Versus Top-Down: Application of New Biological Agents in Pediatric Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 4(9):1094–1096, 2006.CrossRefGoogle Scholar
  23. 23.
    Travis SP, Arrant JM, Ricketts C, et al. Predicting outcome in severe ulcerative colitis. Gut 38:905–10, 1996.PubMedCrossRefGoogle Scholar
  24. 24.
    Werlin SL, Grand RJ. Severe colitis in children and adolescents: diagnosis. Course, and treatment. Gastroenterology 73:828–32, 1977.PubMedGoogle Scholar
  25. 25.
    Hurting WA, Arvanitakis C, Skibba RM, Klotz AP. Treatment of toxic megacolon. A comparative review of 29 patients. Am J Dig Dis 22:195–200, 1977.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Harland Winter
    • 1
  1. 1.Pediatric GI Unit-MGHBostonUSA

Personalised recommendations